NAUT
Nautilus Biotechnology, Inc.NASDAQHealthcare$3.31-1.49%ClosedMarket Cap: $418.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.69
P/S
0.00
EV/EBITDA
-8.41
DCF Value
$-0.15
FCF Yield
-12.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-33.6%
ROA
-30.9%
ROIC
-35.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-15.4M | $-13.8M | $-0.11 | — |
| FY 2025 | $0.00 | -Infinity% | $-66.8M | $-59.0M | $-0.47 | — |
| Q3 2025 | $0.00 | -Infinity% | $-15.5M | $-13.6M | $-0.11 | — |
| Q2 2025 | $0.00 | -Infinity% | $-17.1M | $-15.0M | $-0.12 | — |
| Q1 2025 | $0.00 | -Infinity% | $-18.8M | $-16.6M | $-0.13 | — |
| Q4 2024 | $0.00 | -Infinity% | $-20.0M | $-17.6M | $-0.14 | — |
| FY 2024 | $0.00 | -Infinity% | $-81.5M | $-70.8M | $-0.56 | — |
| Q3 2024 | $0.00 | -Infinity% | $-19.1M | $-16.4M | $-0.13 | — |
| Q2 2024 | $0.00 | -Infinity% | $-20.8M | $-18.0M | $-0.14 | — |
| Q1 2024 | $0.00 | -Infinity% | $-21.6M | $-18.7M | $-0.15 | — |
| Q4 2023 | $0.00 | -Infinity% | $-20.0M | $-17.0M | $-0.14 | — |
| FY 2023 | $0.00 | -Infinity% | $-76.2M | $-63.7M | $-0.51 | — |